ATE430734T1 - Isochinoline und deren herstellung - Google Patents

Isochinoline und deren herstellung

Info

Publication number
ATE430734T1
ATE430734T1 AT03020565T AT03020565T ATE430734T1 AT E430734 T1 ATE430734 T1 AT E430734T1 AT 03020565 T AT03020565 T AT 03020565T AT 03020565 T AT03020565 T AT 03020565T AT E430734 T1 ATE430734 T1 AT E430734T1
Authority
AT
Austria
Prior art keywords
isochinolines
production
Prior art date
Application number
AT03020565T
Other languages
English (en)
Inventor
John-Joseph Savarese
Roy-Archibald Swaringen
Vincente Samano
Original Assignee
Avera Pharmaceuticals Inc
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706117.0A external-priority patent/GB9706117D0/en
Priority claimed from GBGB9724987.4A external-priority patent/GB9724987D0/en
Application filed by Avera Pharmaceuticals Inc, Cornell Res Foundation Inc filed Critical Avera Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE430734T1 publication Critical patent/ATE430734T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03020565T 1997-03-25 1998-03-23 Isochinoline und deren herstellung ATE430734T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9706117.0A GB9706117D0 (en) 1997-03-25 1997-03-25 Ultra-short acting neuromuscular blockers
GBGB9724987.4A GB9724987D0 (en) 1997-11-27 1997-11-27 Ultra-short acting neuromuscular blockers

Publications (1)

Publication Number Publication Date
ATE430734T1 true ATE430734T1 (de) 2009-05-15

Family

ID=26311255

Family Applications (3)

Application Number Title Priority Date Filing Date
AT98912494T ATE295351T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker
AT03020565T ATE430734T1 (de) 1997-03-25 1998-03-23 Isochinoline und deren herstellung
AT98922626T ATE254107T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98912494T ATE295351T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98922626T ATE254107T1 (de) 1997-03-25 1998-03-23 Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker

Country Status (36)

Country Link
US (2) US6177445B1 (de)
EP (4) EP0975599B1 (de)
JP (3) JP4112016B2 (de)
KR (2) KR100578443B1 (de)
CN (1) CN1203061C (de)
AP (1) AP1797A (de)
AR (1) AR012156A1 (de)
AT (3) ATE295351T1 (de)
AU (2) AU6730598A (de)
BR (1) BR9808422B1 (de)
CA (1) CA2284802C (de)
CO (1) CO4940499A1 (de)
CZ (1) CZ293786B6 (de)
DE (3) DE69830157T2 (de)
DK (2) DK0971898T3 (de)
EA (1) EA002224B1 (de)
EE (1) EE04113B1 (de)
ES (2) ES2210757T3 (de)
HR (1) HRP980157B1 (de)
HU (1) HU228230B1 (de)
ID (1) ID22901A (de)
IL (1) IL131918A (de)
IS (2) IS2346B (de)
MA (1) MA26476A1 (de)
MY (1) MY121316A (de)
NO (1) NO314726B1 (de)
NZ (1) NZ337797A (de)
PE (1) PE68399A1 (de)
PL (1) PL190860B1 (de)
PT (2) PT971898E (de)
RS (1) RS49869B (de)
SI (1) SI0975599T1 (de)
TR (1) TR199902330T2 (de)
TW (1) TW505635B (de)
UY (1) UY24933A1 (de)
WO (2) WO1998042675A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203061C (zh) * 1997-03-25 2005-05-25 艾弗拉药品公司 取代异喹啉类，其制备方法，药物组合物及其制药用途
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US6844904B2 (en) * 2002-12-07 2005-01-18 Cubic Corporation Fast PDLC device
WO2005041960A2 (en) * 2003-10-28 2005-05-12 Cornell Research Foundation, Inc. Neuromuscular blocking agents and antagonists thereof
AU2007328210B2 (en) 2006-12-06 2012-11-22 Cornell Research Foundation, Inc. Intermediate duration neuromuscular blocking agents and antagonists thereof
AU2008222298A1 (en) 2007-03-08 2008-09-12 Chemagis Ltd. (1R,1'R)-atracurium salts separation process
EP2125743A1 (de) * 2007-03-26 2009-12-02 Chemagis Ltd. Verfahren zur auftrennung von (1r,1'r)-atracuriumsalzen
CA2685488A1 (en) * 2007-05-01 2008-11-06 Chemagis Ltd. Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates
US8293912B2 (en) * 2007-05-01 2012-10-23 Chemagis Ltd. Process for producing cisatracurium compounds and associated intermediates
CA2687157A1 (en) * 2007-06-18 2008-12-24 Chemagis Ltd. (1r,1'r)-atracurium salts separation process
BRPI0812625A2 (pt) * 2007-07-09 2019-02-19 Chemagis Ltd processo para preparar um sal de cis-atracúrio
CA2702535A1 (en) 2007-10-29 2009-05-07 Chemagis Ltd. Novel r,r'-atracurium salts
CA2722651A1 (en) * 2008-05-01 2009-11-05 Chemagis Ltd. Cisatracurium derivatives, preparation and uses thereof
US8592451B2 (en) 2009-03-17 2013-11-26 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9220700B2 (en) 2009-08-19 2015-12-29 Cornell University Cysteine for physiological injection
JP6236077B2 (ja) * 2012-06-29 2017-11-22 コーネル・ユニバーシティーＣｏｒｎｅｌｌ Ｕｎｉｖｅｒｓｉｔｙ 持続時間が超短期、短期、または中期の非対称性逆転可能神経筋遮断物質
CN103373959A (zh) * 2013-06-14 2013-10-30 安徽省先锋制药有限公司 顺式苄基异喹啉类化合物的制备方法及其用途
WO2014210369A2 (en) * 2013-06-28 2014-12-31 Cornell University Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents
CN108375644B (zh) * 2016-12-07 2021-11-30 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂中间体的分析方法
CN108938573B (zh) * 2017-05-26 2021-08-10 四川科瑞德制药股份有限公司 一种神经肌肉阻滞剂组合物及其制备方法和用途
CN110776481B (zh) * 2018-07-24 2023-06-16 四川大学华西医院 一类双阳离子化合物及其制备方法和用途
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN111662230A (zh) * 2019-03-06 2020-09-15 四川道珍科技有限公司 一类苄基异喹啉化合物、制备方法和用途
CN110117297A (zh) * 2019-04-10 2019-08-13 珠海市赛纬电子材料股份有限公司 一种2-磷酸盐基硫酸丙烯酯的制备方法
WO2021115413A1 (zh) * 2019-12-11 2021-06-17 江苏恒瑞医药股份有限公司 神经肌肉阻滞剂及其制备方法
CN111471013B (zh) * 2020-05-26 2021-04-30 朗天药业(湖北)有限公司 一种米库氯铵及其注射液的制备方法
CN111909089B (zh) * 2020-08-14 2023-04-14 广东嘉博制药有限公司 一种米库氯铵对照品的制备方法
CN114057642B (zh) * 2021-12-10 2023-03-28 广东嘉博制药有限公司 一种米库氯铵中间体的合成方法
CN115073373A (zh) * 2022-07-08 2022-09-20 广东嘉博制药有限公司 一种不对称合成（r）-5’-甲氧基劳丹素的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3004031A (en) * 1958-07-03 1961-10-10 Allen & Hauburys Ltd Diquaternary salts of papaverino esters
AU506657B2 (en) * 1975-12-10 1980-01-17 Wellcome Foundation Limited, The Isoquinoline derivatives
NL7808067A (nl) * 1977-08-01 1979-02-05 Massachusetts Gen Hospital Werkwijze voor het bereiden van een middel dat zenuw- spieren blokkeert.
US4701460A (en) * 1980-12-17 1987-10-20 Burroughs Wellcome Co. Long duration neuromuscular blocking agents
JPS5899465A (ja) * 1981-11-23 1983-06-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド イソキノリン誘導体
GB8418303D0 (en) * 1984-07-18 1984-08-22 Wellcome Found Compounds
BG41897A1 (en) * 1985-07-19 1987-09-15 Ivanov Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation
GB9015473D0 (en) * 1990-07-13 1990-08-29 Wellcome Found Neuromuscular blocking agents
JPH04112016A (ja) * 1990-09-03 1992-04-14 Fuji Electric Co Ltd トランスファ成形金型用プランジャ及びトランスファ成形装置
US5240939A (en) * 1991-10-31 1993-08-31 Anaquest, Inc. Nitrogen bridge tetrahydroisoquinolines
CN1203061C (zh) * 1997-03-25 2005-05-25 艾弗拉药品公司 取代异喹啉类，其制备方法，药物组合物及其制药用途

Also Published As

Publication number Publication date
EE04113B1 (et) 2003-08-15
BR9808422B1 (pt) 2010-08-24
HUP0001556A3 (en) 2002-01-28
HRP980157B1 (en) 2004-10-31
PL190860B1 (pl) 2006-02-28
NO314726B1 (no) 2003-05-12
SI0975599T1 (en) 2004-04-30
JP2002517168A (ja) 2002-06-11
JP4112016B2 (ja) 2008-07-02
KR20010005621A (ko) 2001-01-15
JP2002503220A (ja) 2002-01-29
IL131918A0 (en) 2001-03-19
EP1380573A3 (de) 2004-01-21
DE69840816D1 (de) 2009-06-18
EP0971898A1 (de) 2000-01-19
PT975599E (pt) 2004-03-31
JP2008019272A (ja) 2008-01-31
MY121316A (en) 2006-01-28
EE9900424A (et) 2000-04-17
AU6730598A (en) 1998-10-20
TR199902330T2 (xx) 2000-02-21
CN1203061C (zh) 2005-05-25
WO1998042674A1 (en) 1998-10-01
EP1380573B1 (de) 2009-05-06
EP1380573A2 (de) 2004-01-14
JP4112015B2 (ja) 2008-07-02
IS5185A (is) 1999-09-17
DK0975599T3 (da) 2004-03-15
NO994680D0 (no) 1999-09-24
HU228230B1 (en) 2013-02-28
WO1998042675A1 (en) 1998-10-01
UY24933A1 (es) 2000-12-29
CN1257483A (zh) 2000-06-21
AU745382B2 (en) 2002-03-21
HRP980157A2 (en) 1999-02-28
KR100554601B1 (ko) 2006-03-03
EP1526130A1 (de) 2005-04-27
TW505635B (en) 2002-10-11
CO4940499A1 (es) 2000-07-24
US6177445B1 (en) 2001-01-23
ES2210757T3 (es) 2004-07-01
MA26476A1 (fr) 2004-12-20
CA2284802C (en) 2009-06-16
AP9901658A0 (en) 1999-09-30
YU48399A (sh) 2002-06-19
BR9808422A (pt) 2000-05-23
EA002224B1 (ru) 2002-02-28
AR012156A1 (es) 2000-09-27
CA2284802A1 (en) 1998-10-01
NO994680L (no) 1999-11-24
IS8717A (is) 2008-03-03
CZ340499A3 (cs) 2000-04-12
DE69830157T2 (de) 2006-05-11
CZ293786B6 (cs) 2004-07-14
DE69819703T2 (de) 2004-09-30
AU7521098A (en) 1998-10-20
KR100578443B1 (ko) 2006-05-11
RS49869B (sr) 2008-08-07
HUP0001556A2 (hu) 2001-04-28
ID22901A (id) 1999-12-16
DK0971898T3 (da) 2005-09-05
ATE295351T1 (de) 2005-05-15
PE68399A1 (es) 1999-07-23
ES2242275T3 (es) 2005-11-01
EP0975599B1 (de) 2003-11-12
EA199900756A1 (ru) 2000-08-28
HK1023342A1 (en) 2000-09-08
US6187789B1 (en) 2001-02-13
EP0971898B1 (de) 2005-05-11
AP1797A (en) 2007-11-15
DE69819703D1 (de) 2003-12-18
DE69830157D1 (de) 2005-06-16
EP0975599A1 (de) 2000-02-02
NZ337797A (en) 2001-03-30
KR20050103984A (ko) 2005-11-01
ATE254107T1 (de) 2003-11-15
IL131918A (en) 2005-09-25
PL335885A1 (en) 2000-05-22
PT971898E (pt) 2005-07-29
IS2346B (is) 2008-03-15

Similar Documents

Publication Publication Date Title
DE69840816D1 (de) Isochinoline und deren Herstellung
DE69821951D1 (de) Bernsteinsäure herstellung und reinigung
EP0790826A4 (de) Dyhydropyrimidine und deren verwendungen
DE69929456D1 (de) Nahfeldabtastkopf und herstellungsverfahren
DE69808499D1 (de) Widerstand und herstellungsverfahren
DE69825434D1 (de) Schirmgehäuse und dessen herstellungsverfahren
DE69634852D1 (de) Modulaire stuhlkonstruktion und zusammenbauverfahren
DE69838849D1 (de) Mehrchipmodulstruktur und seine herstellung
DE69937352D1 (de) Maiszellulosesynthasen und deren verwendungen
DE69637728D1 (de) Halbleiterbauteil und Herstellung desselben
ATE284392T1 (de) Substituierte 2-phenylbenzimidazole, deren herstellung und anwendung
DE69506946D1 (de) Microporöse Keramiken und deren Herstellung
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
DE69503139D1 (de) Schuhwerk und dessen herstellung
DE69931405D1 (de) Haftverschlüsse und deren Herstellung
DE69516198D1 (de) Textil-Strukturen und ihre Herstellung
LV12624B (lv) Tienilazolilalkosietanamini to iegusanas panemiens un pielietojums medikamentu legusana
DE69831750D1 (de) Biozide und biozide tücher
DE69904731D1 (de) Feinzerkleinerer und feinzerkleinerungsverfahren
ATE280192T1 (de) Neue blockpolymere und deren herstellung
DE69821551D1 (de) Folientastatur und deren Herstellungsmethoden
DE69820182D1 (de) Bodenbelag und zugehöriges Herstellungsverfahren
DE69532131D1 (de) Heizvorrichtung und ihre herstellung
DE69317265D1 (de) Konstruktionselement und dessen herstellung
DE69510496D1 (de) Microporösen Kermamiken und deren Herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties